Related references
Note: Only part of the references are listed.Histamine Promotes Osteoclastogenesis through the Differential Expression of Histamine Receptors on Osteoclasts and Osteoblasts
Martin Biosse-Duplan et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Mast cell chymase contributes to the antibody response and the severity of autoimmune arthritis
Sofia E. Magnusson et al.
FASEB JOURNAL (2009)
Mast Cells Contribute to Autoimmune Inflammatory Arthritis via Their Tryptase/Heparin Complexes
Kichul Shin et al.
JOURNAL OF IMMUNOLOGY (2009)
RANK/RANKL: Regulators of Immune Responses and Bone Physiology
Andreas Leibbrandt et al.
YEAR IN IMMUNOLOGY 2008 (2008)
Tranilast, an orally active anti-allergic drug, up-regulates the anti-inflammatory heme oxygenase-1 expression but down-regulates the pro-inflammatory cyclooxygenase-2 and inducible nitric oxide synthase expression in RAW264.7 macrophages
Hyun-Ock Pae et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Suppressive effects of tranilast on eotaxin-1 production from cultured conjunctival fibroblasts
Richard Yudi Hida et al.
CURRENT EYE RESEARCH (2008)
The role and therapeutic implications of fibroblast-like synoviocytes in inflammation and cartilage erosion in rheumatoid arthritis
Erika H. Noss et al.
IMMUNOLOGICAL REVIEWS (2008)
Role of cytokines in rheumatoid arthritis: an education in pathophysiology and therapeutics
Marc Feldmann et al.
IMMUNOLOGICAL REVIEWS (2008)
The extended cleavage specificity of the rodent β-chymases rMCP-1 and mMCP-4 reveal major functional similarities to the human mast cell chymase
Mattias K. Andersson et al.
MOLECULAR IMMUNOLOGY (2008)
The anti-allergic drug, N-(3′,4′-dimethoxycinnamonyl) anthranilic acid, exhibits potent anti-inflammatory and analgesic properties in arthritis
J. J. Inglis et al.
RHEUMATOLOGY (2007)
Tranilast suppresses the disease development of the adjuvant- and streptococcal cell wall-induced arthritis in rats
Toshiaki Nagate et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2007)
Mast cells in the pathogenesis of rheumatic diseases and as potential targets for anti-rheumatic therapy
Kari K. Eklund
IMMUNOLOGICAL REVIEWS (2007)
Pathophysiological role of mast cells in collagen-induced arthritis: Study with a cysteinyl leukotriene receptor antagonist, montelukast
Naotaka Shiota et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
Mast cells in atherosclerosis as a source of the cytokine RANKL
Ahmed Salem Ali et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2006)
Effect of tranilast on matrix metalloproteinase production from neutrophils in-vitro
T Shimizu et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2006)
Treatment of autoimmune neuroinflammation with a synthetic tryptophan metabolite
M Platten et al.
SCIENCE (2005)
Suppression of matrix metalloproteinase production in nasal fibroblasts by tranilast, an antiallergic agent, in vitro
T Shimizu et al.
MEDIATORS OF INFLAMMATION (2005)
Inhibition of c-kit tyrosine kinase by imatinib mesylate induces apoptosis in mast cells in rheumatoid synovia:: a potential approach to the treatment of arthritis
A Juurikivi et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
Tranilast attenuates vascular hypertrophy, matrix accumulation and growth factor overexpression in experimental diabetes
F Bonnet et al.
DIABETES & METABOLISM (2003)
Histamine stimulates production of osteoclast differentiation factor/receptor activator of nuclear factor-κB ligand by osteoblasts
Y Deyama et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Tranilast inhibits cytokine-induced nuclear factor κB activation in vascular endothelial cells
M Spiecker et al.
MOLECULAR PHARMACOLOGY (2002)
Mast cells: A cellular link between autoantibodies and inflammatory arthritis
DM Lee et al.
SCIENCE (2002)
Evidence for a role of mast cells in the evolution to congestive heart failure
M Hara et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Tranilast inhibits interleukin-1β-induced monocyte chemoattractant protein-1 expression in rat mesangial cells
A Chikaraishi et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2001)
Isoform-selective upregulation of mast cell chymase in the development of skin fibrosis in scleroderma model mice
E Kakizoe et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2001)